WW stock popped after announcing a new compounded semaglutide product to benefit from the current shortage of weight loss ...

WW International (WW) shares surged more than 20% in early trading on Wednesday after Morgan Stanley said the company's ...

WW International, Inc. (NASDAQ:WW – Get Free Report) was the target of unusually large options trading on Wednesday. Traders purchased 17,056 call options on the company. This is an increase of 1,502% ...

Despite subscriber declines, WW International Inc (WW) reports strong clinical revenue growth and strategic cost-saving ...

In a report released today, Alex Fuhrman from Craig-Hallum maintained a Hold rating on WW International (WW – Research Report), with a ...

Stephanie Davis, an analyst from Barclays, maintained the Sell rating on WW International (WW – Research Report). The associated price ...

WW International has removed CEO Sima Sistani from the chief executive role effective immediately, the company previously ...

Analysts maintain a pessimistic view of WeightWatchers parent company WW International ($WW) despite investors new found ...

WW International, known as WeightWatchers, saw its stock soar on new of its new compounded GLP-1 offering. But analysts say that's only a short-term solution to its ailing business.

WW International Inc (WW) stock saw a modest uptick, ending the day at $0.75 which represents a slight increase of $0.03 or 4.17% from the prior close of $0.72. The stock opened at $0.73 and touched a ...

A recently released negative study by Novo Nordisk (NVO) on the differences between its own semaglutide and liraglutide ...

The executive led the diet company, better known as WeightWatchers, since 2022 into the burgeoning market for obesity drugs.